Sbicap Securities

State Bank of India's stock broking arm, SBICap Securities, which has been growing at over 60 percent so far this year in customer addition, today said for the first time the company will turn in a small profit this fiscal, driven by the retail portfolio.

Auto, FMCG, consumer durables to benefit from GST: SBICap

Mahantesh Sabarad of SBICap Securities believes various sectors will be impacted by the rate of Goods and Services Tax (GST), expected to be around 18 percent.

US elections pose risks to pharma sector: SBICap

The entire business model of pharma companies in the US comprising of substantial filings, inspection of facilities & FDA compliance and marketing distributing strategy is threatened at present, says Mahantesh Sabarad, Deputy VP Research, SBICap Securities.

Dish TV looks attractive, says Mahantesh Sabarad

Mahantesh Sabarad of SBICAP Securities is of the view that Dish TV is looking attractive.

YES Bank may move to Rs 1050-1060: Mahantesh Sabarad

Mahantesh Sabarad of SBICAP Securities feels that YES Bank may move to Rs 1050-1060.

Look at Maruti Suzuki, says Mahantesh Sabarad

Mahantesh Sabarad of SBICAP Securities is of the view that one may look at Maruti Suzuki.

Buy United Breweries, says Mahantesh Sabarad

Mahantesh Sabarad of SBICAP Securities suggests buying United Breweries.

Buy Nestle India, says Mahantesh Sabarad

Mahantesh Sabarad of SBICAP Securities is of the view that one may buy Nestle India.

Bullish on overall mkt; like Nestle, Maruti, Yes Bank:SBICAP Sec

Stock specific Mahantesh Sabarad of SBICAP Securities is very bullish on Nestle India and Maruti and have target price of Rs 6800 and Rs 4900 respectively.

Slight NPA increase for IndusInd acceptable: Analysts

A marginal rise in provisioning and a slight deterioration in gross NPL of IndusInd Bank was expected given the economic environment and should be taken positively as the corporate portfolios of all the banks are under considerable pressure, says Hemindra Hazari, Independent Market Expert.

Here are some top trading ideas from Mahantesh Sabarad

Watch the interview of Mahantesh Sabarad of SBICap Securities with Anuj Singhal & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

Cautious on pharma space, says Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research, SBICap Securities has a cautious view on the pharma space.

Like JK Tyre and Industries: Mahantesh Sabarad

Mahantesh Sabarad, Deputy VP-Research, SBICap Securities likes JK Tyre and Industries from the tyre space.

Here are some stock picks from Mahantesh Sabarad

Watch the interview of Mahantesh Sabarad, Deputy VP-Research, SBICap Securities with Ekta Batra and Anuj Singhal on CNBC-TV18, in which he shared his reading and outlook on market and specific stocks.

Buy CCL Products, Can Fin Homes, Repco Home: Rajesh Gupta

Rajesh Gupta, Assistant Vice President at SBICAP Securities recommends buying CCL Products, Can Fin Homes and Repco Home Finance.

Here are Rajesh Gupta's top trading ideas

Rajesh Gupta, Assistant Vice President at SBICAP Securities recommends buying CCL Products India,Can Fin Home and Repco Home Finance.

Mkt downside capped between 7800-8000; like cement: SBICap

Amongst the cement companies, Mahantesh Sabarad of SBICap Securities prefers regional players that are exposed to central and eastern parts of the country than largecap names. He likes Heidelberg from that space

Revenue miss: How will D-Street react to TCS' nos?

Sarabjit Kaur Nangra, VP-research from Angel Broking says while the revenue miss is disappointing, but the core matrix drivers in terms of volume has done fairly well. The miss has probably come from currency, she adds

Nestle attractive now; buy Oberoi Realty: SBICap Securities

Watch the interview of Mahantesh Sabarad, Dy VP-Research at SBICap Securities with Anuj Singhal & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

Valuations attractive now; like banking, infra: SBICap

Sabarad of SBICap Securities is bullish on the infrastructure and banking themes, and wary of auto-ancillary firms with sizeable exposure to European markets.

Positive on fin NBFCs, select pharma cos: SBICap Sec

Mahantesh Sabarad of SBICAP Securities is bullish on financial NBFC space, select pharma companies and IT stocks. He likes PTC India, Dr Reddy's Lab, Biocon, Infosys and Firstsource, among others.

Prefer Infy over TCS; Nifty EPS at Rs 634 for '16-17:SBICap

Mahantesh Sabarad, Deputy VP-Research, SBICap Securities gives his view on whether there is a possibility of earnings per share (EPS) downgrades post June quarter and also his take on Tata Consultancy Services (TCS).

RBI rate cut next trigger for mkt; buy Jubilant: SBICap Sec

Mahantesh Sabarad, deputy VP - Research, SBICap Securities likes the construction space and is bullish on Ashoka Buildcon and Sadbhav Engineering.

Here are Mahantesh Sabarad's few trading ideas

Watch the interview of Mahantesh Sabarad, Dy VP – Research at SBICap Securities with Anuj Singhal & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.

Swachh Budget...Swachh India: SBICap

The proposed introduction of a gold deposit scheme is a big positive and conservative estimates show that the monetary value of gold deposits mobilized may be at least Rs 1 lakh crore.